Bosh sahifaCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Yopilish kursi
7,33 $
Yillik diapazon
5,25 $ - 22,20 $
Bozor kapitalizatsiyasi
2,03 mln USD
Oʻrtacha hajm
370,00
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 4,00 ming | -98,93% |
Joriy xarajat | 3,65 mln | -42,11% |
Sof foyda | -3,26 mln | 40,22% |
Sof foyda marjasi | -81,42 ming | -5 474,80% |
Har bir ulushga tushum | -0,72 | 89,09% |
EBITDA | -3,64 mln | 38,49% |
Amaldagi soliq stavkasi | 11,23% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 6,00 mln | -40,97% |
Jami aktivlari | 8,19 mln | -50,19% |
Jami passivlari | 7,19 mln | -36,40% |
Umumiy kapital | 999,00 ming | — |
Tarqatilgan aksiyalar | 1,97 mln | — |
Narxi/balansdagi bahosi | 13,33 | — |
Aktivlardan daromad | -126,92% | — |
Kapitaldan daromad | 1 542,76% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -3,26 mln | 40,22% |
Operatsiyalardan naqd pul | -3,08 mln | -136,32% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 6,29 mln | 12 431,37% |
Naqd pulning sof oʻzgarishi | 3,20 mln | 351,93% |
Boʻsh pul | -2,94 mln | -93,08% |
Haqida
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. Wikipedia
Tashkil etilgan
13-avg, 1996
Sayt
Xodimlar soni
12
